Koninklijke Philips NV vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Koninklijke Philips NV trades at $26.3 (market cap $25.89B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.5. The key difference: Koninklijke Philips NV pays a 3.81% dividend while Vanguard Global ex-US Real Estate Index Fd ETF pays none, and Vanguard Global ex-US Real Estate Index Fd ETF is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| PHG | VNQI | |
|---|---|---|
Market Cap | $25.89B | — |
Sector | Health | — |
52-Week High | $32.91 | $50.76 |
52-Week Low | $25.02 | $43.26 |
Enterprise Value | $32.18B | — |
Dividend Yield | 3.81% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $45.69, showing minimal daily movement with a slight 0.07% decline. The technical picture remains bearish with moving averages signaling caution, though oscillators are neutral. The fund provides international real estate diversification with 682 holdings across 30+ countries, featuring a low 0.12% expense ratio and attractive 4.6% dividend yield. Recent analysis highlights its role as a cost-effective diversifier for U.S.-focused real estate portfolios.
VNQI offers exposure to recovering global real estate markets with transaction volumes expected to grow over 10% in 2026. The fund trades at attractive valuations (0.9x P/B, 11.9x P/E) but faces headwinds from international market volatility and currency risks. While providing yield advantages over domestic peers, its total returns have lagged, making it suitable for investors seeking international diversification and income rather than growth leadership.
Trailing returns across standard periods
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →